1136484
Toyobo Co. Ltd. — FEI 1000251214
Inspection Details
- Classification
- Official Action Indicated (OAI) (OAI)
- End Date
- February 25, 2021
- Fiscal Year
- 2021
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Otsu (Japan)
Citations
| ID | CFR | Description |
| 1105 | 21 CFR 211.22(d) | Procedures not in writing, fully followed |
| 1112 | 21 CFR 211.25(a) | Training--operations, GMPs, written procedures |
| 1163 | 21 CFR 211.28(b) | Habits of good sanitation & health |
| 1263 | 21 CFR 211.68(b) | Computer control of master formula records |
| 1358 | 21 CFR 211.100(b) | SOPs not followed / documented |
| 1434 | 21 CFR 211.42(c)(10)(iv) | Environmental Monitoring System |
| 2027 | 21 CFR 211.192 | Investigations of discrepancies, failures |
| 2031 | 21 CFR 211.194(a) | Complete test data included in records |
| 4376 | 21 CFR 211.188(b)(4) | Weights and measures of components used |
| 4402 | 21 CFR 211.192 | Written record of investigation incomplete |
| 4406 | 21 CFR 211.194(a)(2) | Suitability of testing methods verified |